TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
0.4582
-0.0040 (-0.87%)
At close: Apr 4, 2025, 4:00 PM
0.4620
+0.0038 (0.82%)
After-hours: Apr 4, 2025, 4:34 PM EDT

TransCode Therapeutics Statistics

Total Valuation

RNAZ has a market cap or net worth of $10.70 million. The enterprise value is $8.16 million.

Market Cap 10.70M
Enterprise Value 8.16M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

RNAZ has 23.34 million shares outstanding.

Current Share Class 23.34M
Shares Outstanding 23.34M
Shares Change (YoY) n/a
Shares Change (QoQ) +108.27%
Owned by Insiders (%) 0.15%
Owned by Institutions (%) 0.84%
Float 23.31M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.15
P/TBV Ratio 5.98
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.09.

Current Ratio 1.58
Quick Ratio 0.82
Debt / Equity 0.09
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -346.50

Financial Efficiency

Return on equity (ROE) is -490.03% and return on invested capital (ROIC) is -268.05%.

Return on Equity (ROE) -490.03%
Return on Assets (ROA) -129.43%
Return on Invested Capital (ROIC) -268.05%
Return on Capital Employed (ROCE) -887.68%
Revenue Per Employee n/a
Profits Per Employee -$1.49M
Employee Count 10
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.05% in the last 52 weeks. The beta is 1.52, so RNAZ's price volatility has been higher than the market average.

Beta (5Y) 1.52
52-Week Price Change -98.05%
50-Day Moving Average 4.53
200-Day Moving Average 11.57
Relative Strength Index (RSI) 27.55
Average Volume (20 Days) 16,909,032

Short Selling Information

The latest short interest is 339,770, so 1.46% of the outstanding shares have been sold short.

Short Interest 339,770
Short Previous Month 540,931
Short % of Shares Out 1.46%
Short % of Float 1.46%
Short Ratio (days to cover) 0.15

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -14.67M
Pretax Income -17.06M
Net Income -14.93M
EBITDA -14.55M
EBIT -14.67M
Earnings Per Share (EPS) -$71.81
Full Income Statement

Balance Sheet

The company has $1.88 million in cash and $152,481 in debt, giving a net cash position of $1.72 million or $0.07 per share.

Cash & Cash Equivalents 1.88M
Total Debt 152,481
Net Cash 1.72M
Net Cash Per Share $0.07
Equity (Book Value) 1.65M
Book Value Per Share 3.16
Working Capital 1.33M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.85 million and capital expenditures -$21,261, giving a free cash flow of -$15.87 million.

Operating Cash Flow -15.85M
Capital Expenditures -21,261
Free Cash Flow -15.87M
FCF Per Share -$0.68
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RNAZ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -151.00%
FCF Yield -160.59%

Analyst Forecast

The average price target for RNAZ is $20.00, which is 4,264.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.00
Price Target Difference 4,264.91%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 18.78%
EPS Growth Forecast (5Y) -1.11%
Stock Forecasts

Stock Splits

The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.030303:1.

Last Split Date Dec 4, 2024
Split Type Reverse
Split Ratio 0.030303:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a